Skip to main content
. 2020 May 29;10:8764. doi: 10.1038/s41598-020-65059-0

Figure 3.

Figure 3

LNP-formulation of the ANDV DNA vaccine increases immunogenicity in nonhuman primates. Cynomolgus macaques were vaccinated with either 0.1 mg of LNP-formulated or unformulated ANDV DNA vaccine and boosted 28 Days later. A third group received a dose utilized in clinical studies (2.0 mg) and was boosted a second time on Day 56. (A) Legend. (B) Sera were analyzed for the presence of neutralizing antibody via a PsVNA and GMT were plotted.